Use of IL-20 antagonists for treating liver diseases

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
Original languageEnglish
Patent number8603470
Publication statusPublished - 1800

    Fingerprint

Cite this